Latest Articles

FDA Approves Bavencio for Merkel Cell Carcinoma
BY JASON M. BRODERICK
Bavencio (avelumab), a PD-L1-inhibitor, gained approval by the Food and Drug Administration (FDA) for some patients with Merkel cell carcinoma. 
Advancements Continue in HER2-Positive Breast Cancer
BY DANIELLE BUCCO
Sara Hurvitz, M.D. talks about recent and upcoming advancements in the treatment of HER2-positive breast cancer
Surgery Is Still Crucial for Melanoma Treatment
BY GINA COLUMBUS
Kiran K. Turaga explains that, even with all the advancements and novel treatments in melanoma, surgery is still critical. 
Car T Cell Therapy Being Tested in Pancreatic Cancer
BY BETH FAND INCOLLINGO
Experimental treatment uses engineered T cells to target prostate stem cell antigen.
NCCN Launches New Distress Resources for Patients With Cancer
BY KATIE KOSKO
The NCCN created new free, online resources for patients with cancer who are experiencing distress.
Avoiding Amputation in Patients With Sarcoma
BY DANIELLE BUCCO
John E. Mullinax, M.D., discusses a chemotherapy strategy that may be able to save the limbs of some patients with sarcoma. 
Research Advances to Improve Treatments for Patients with GBM
BY LAUREN M. GREEN
As researchers test new treatments for GBM, understanding the unique needs of patients with this diagnosis and their caregivers remains crucial.
Side Matters in Colorectal Cancer
BY ERIK NESS
Whether a cancer arises on the left or right side of the colon can affect both prognosis and treatment.
Can the Chickenpox Protect Patients Against Glioma?
BY BRIELLE URCIUOLI
A recent study found that individuals who had the chickenpox virus when they were younger were less likely to eventually develop gliomas.